NRF2 Regulator Aryl Analogs for Oxidative Stress
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for various diseases such as COPD, asthma, and cardiovascular conditions lack effective NRF2 regulators, which are crucial for managing oxidative stress and inflammation, leading to suboptimal patient outcomes.
Innovation Solution
Development of aryl analogs and pharmaceutical compositions that act as NRF2 regulators, potentially combined with other agents like anti-histamines, corticosteroids, or bronchodilators, to enhance NRF2 activity and mitigate oxidative stress and inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments (anti-histamines, corticosteroids, bronchodilators) are used, then symptoms of respiratory diseases are managed, but oxidative stress and inflammation are not effectively addressed
Solution Approach 1:
The patent combines conventional respiratory treatments (anti-histamines, corticosteroids, bronchodilators) with NRF2 regulator compounds in a single formulation. This merging allows the synergistic effect of both treatment types to address both symptomatic relief and underlying oxidative stress/inflammation simultaneously, resolving the contradiction between symptom management and addressing harmful factors.
Solution Approach 2:
NRF2 regulator compounds act as intermediary agents that bridge conventional treatments and the oxidative stress/inflammation pathway. These compounds activate the NRF2 pathway, which mediates the protective response against oxidative stress and inflammation, thereby enhancing the overall effectiveness of the treatment regimen.
2Reliability
If NRF2 activity is restored, then cytoprotection and bacterial clearance are improved, but disease progression is slowed rather than reversed
Solution Approach 1:
The NRF2 regulator compounds are administered proactively to restore NRF2 activity before severe tissue damage occurs. This preliminary action maintains cytoprotection and bacterial clearance capabilities, preventing further disease progression rather than reversing established damage, which aligns with the observed therapeutic effect.
3Object-affected harmful factors
If aryl analogs are developed as NRF2 regulators, then oxidative stress is reduced, but the complexity of pharmaceutical compositions increases
Solution Approach 1:
The aryl analog NRF2 regulator compounds are designed with multi-functionality, addressing oxidative stress, inflammation, and bacterial clearance through a single molecular mechanism. This universality reduces the need for multiple separate drugs, thereby managing composition complexity while effectively reducing oxidative stress and other harmful factors.
Data Source
AI summary
The present invention relates to compositions comprising the compounds of formula (I) for their use as NRF2 regulators